kanamycin A(4+)

CHEBI:CHEBI_58214

Definition

A quadruply-charged organic cation arising from protonation of the four amino groups of kanamycin A; major species at pH 7.3.

Chemical Information

Molecular Formula
C18H40N4O11
Molecular Mass
488.53040
Charge
+4
SMILES
[NH3+]C[C@H]1O[C@H](O[C@@H]2[C@@H]([NH3+])C[C@@H]([NH3+])[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H]([NH3+])[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/p+4/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1
InChIKey
SBUJHOSQTJFQJX-NOAMYHISSA-R

Alternative Names

  • kanamycin A
  • (1S,2R,3R,4S,6R)-4,6-diazaniumyl-3-(6-azaniumyl-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-azaniumyl-3-deoxy-alpha-D-glucopyranoside
  • kanamycin A tetracation

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

core#notation
CHEBI:58214

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_17630
owl#someValuesFrom
t136662
owl#annotatedSource
t252324
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#id
CHEBI:58214
core#notation
CHEBI:58214
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_17630
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_76969
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class